The Government of the United States, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research;Crucell Holland B.V.;GlaxoSmithKline Biologicals SA
发明人:
PAU, MARIA GRAZIA,GOUDSMIT, JAAP,COHEN, JOSEPH D.,DUBOIS, PATRICE M.,STEWART, V. ANN,HEPPNER, DONALD
申请号：
PL05808091
公开号：
PL1802336T3
申请日:
2005.10.13
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
Described are vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appropriate adjuvants.
